Story perspectives

AI CEOs Push Mandatory Nucleic-Acid Screening, Senators Back Bill

6/6/2026

Summary

Story summary

CEO Sam Altman, CEO Dario Amodei and CEO Demis Hassabis urged mandatory nucleic-acid screening against bioweapon misuse.
The June 3 2026 “Mandatory Nucleic Acid Screening” letter was organized by the Institute for Progress.
AI systems now outperform PhD-level virologists on lab questions, eroding barriers to bioweapon development.
Senator Tom Cotton and Senator Amy Klobuchar introduced S. 3741, the 2026 Biosecurity Modernization Act, requiring mandatory industry-wide screening and recordkeeping.

History

Historical Context

The 1925 Geneva Protocol banned the use of chemical and biological weapons but allowed possession, leading United States and Soviet Union to maintain offensive programs into the 1960s. Negotiations after Nixon ended the U.S. program in 1969 produced the Biological Weapons Convention, signed 10 April 1972 and effective 26 March 1975 after 22 states ratified, and its legacy now fuels biotech-oversight proposals as synthetic-biology and AI reshape threats.

1 of 2

Story summary

CEO Sam Altman, CEO Dario Amodei and CEO Demis Hassabis urged mandatory nucleic-acid screening against bioweapon misuse.
The June 3 2026 “Mandatory Nucleic Acid Screening” letter was organized by the Institute for Progress.
AI systems now outperform PhD-level virologists on lab questions, eroding barriers to bioweapon development.
Senator Tom Cotton and Senator Amy Klobuchar introduced S. 3741, the 2026 Biosecurity Modernization Act, requiring mandatory industry-wide screening and recordkeeping.

1 / 2